The shareholders in LIDDS AB (publ) (reg. no. 556580-2856) (the “Company” or “LIDDS”) are hereby convened to the Annual General Meeting in Excore’s premises at Kungsportsavenyn 22 in Gothenburg, on Monday 27 May 2024 at 11.00 (CET).
Right to participate and registration
Right to participate at the Annual General Meeting is held by those shareholders who are registered in the share register held by Euroclear Sweden AB on Friday 17 May 2024 and who have given notice to the Company no later than Tuesday 21 May 2024 in writing to LIDDS AB (publ), PO Box 12040, 112 40 Stockholm or by email to info@liddspharma.com.
The notification should state full name, personal code number or corporate ID number, shareholding, address, daytime telephone number and also details of deputy when applicable. When applicable, power of attorney, registration certificates and other authorisation documents should be appended to the notification.
Nominee-registered shares
To be entitled to participate in the Annual General Meeting, shareholders whose shares are held in the name of a nominee must, in addition to providing notification of their participation in the Annual General Meeting, re-register the shares in their own name so that the shareholders are registered in the share register on the record date on Friday, 17 May 2024. This re-registration may be temporary (so-called “voting right registration”) and is carried out through the nominee according to their procedures at a time predetermined by the nominee. Voting rights registration that has been completed by the nominee no later than Tuesday, 21 May 2024, are considered when preparing the share register.
Proxy
Shareholders represented by proxy shall issue dated and signed power of attorney for the proxy. Power of attorney must be provided no later than at the meeting, but preferably through prior submission of a copy. If the power of attorney is issued by a legal entity, attested copies of the certificate of registration (or equivalent document for foriegn legal entity), must be appended to the power of attorney. The power of attorney’s period of validity must be a maximum of five years if specifically indicated. If no period of validity is indicated, the power of attorney applies for a maximum of one year. The company provides a proxy form on the company’s website www.liddspharma.com and a proxy form is also sent to those shareholders who request one and provide their address.
Number of shares and votes
As per 24 April 2024, there are a total of 136,463,326 shares and votes in the Company. The Company holds no own shares.